PeerConnect


photo

Victor Camlek - Analyst Profile

Principal Analyst
Transformational Health
Healthcare

Summary

I'm a veteran market intelligence analyst with extensive experience focused on the Healthcare Information, Telehealth and Telecommuncations sectors.  I have had corporate experience as VP of Market Intelligence for the IP and Science and Healthcare businesses of Thomson Reuters and prior to that various leadership and analyst positions at Telcordia Technologies (now part of Ericsson).  I have done presentations at various global industry conferences. My favorite hobbies include photography, music, sports and travel. 


Areas of expertise
CORPORATE STRATEGY
MARKETING
MARKET RESEARCH
COMPETITIVE INTELLIGENCE


Recent items from Victor Camlek

Top Digital Health Takeaways and Analyst Perspectives
The CHC18 marked the tenth year of this event that is now co-produced by the Personal Connected Health Alliance (PCHA), a HIMSS organization, and Partners HealthCare of Boston. This event has grown from the 1st edition that attracted 750 attendees to this latest edition that included 300 speakers. We were told, unofficially, that the attendance for the 2018 event was up 50% over the previous year. The theme of this year’s Connected Health Conference was, “Balancing Technology and the Human Element.” The conference agenda was a barometer of the key themes of importance to connected healthcare stakeholders. Author: Victor Camlek
Published: Nov 21 2018 Other
Improved Workflow, Operational Efficiency, and Customer Journey Will be Available to All Stakeholders
Frost & Sullivan research found the visible market success of artificial intelligence (AI)-driven interactive virtual assistants (IVAs), such as Alexa from Amazon and the Google Assistant, has been matched by specialized IVA deployments in various vertical markets such as financial services, education, and retail. Healthcare has presented opportunities for enterprise-grade IVAs that can support operational and medical workflows as well as provide various information services directly to patients. This market insight reviews the current market landscape for consumer and healthcare enterprise-grade IVAs. It includes the mass-market brands that have become household members. The healthcare markets are served by several additional participants, including Nuance Dragon, eClinicalWorks Eva, and Alme from Next IT (now part of Verint). The report segments the market into mass-market interactive voice services; healthcare interactive voice services; Voice/speech recognition software and platforms; customer engagement solutions; and AI technology enablers. The input from these segments has benefited patients, caregivers and healthcare professionals. Major questions this report will answer include: · What are the macro trends behind the interest in AI in the mass market and healthcare? · Which companies are providing the mix of voice and speech recognition software and platforms? · Which workflow tasks can become more efficient by offering voice interfaces? · How can physicians benefit from IVAs that are available in an examining room? · What are the AI-driven IVA services that will benefit patients? · What are the benefits associated with currently available IVAs? · What are the strategic imperatives that industry participants must fulfill to ensure ongoing success and market growth? Frost & Sullivan research predicts that the IVA market will evolve over the short term to improve the patient experience by offering an interface that can make decisions, solve problems, and determine when a patient query must be transferred to a human operator to be fully addressed. Moving forward, one should not be surprised to see virtual assistants performing various functions in the medical establishment that will improve the healthcare experience for patients, families, physicians, nurses, and call center workers.
Published: Aug 01 2018 Other
Acquisitions Grab the Headlines as Industry Leaders Brace for Turbulent Times Ahead
The American Telemedicine Association (ATA) held its annual conference and expo in Chicago from April 29 to May 1, with the theme “Learn, Connect, Discover.” The event drew more than 4,200 attendees, including representatives of established and start-up telemedicine and digital healthcare companies and healthcare professionals from provider and payer organizations. The agenda featured informative sessions, educational opportunities, and a large exhibit hall. The 2018 conference was upstaged by two significant acquisition announcements. American Well announced a definitive agreement to acquire Avizia, and InTouch Health announced a definitive agreement to acquire REACH Health. This news created significant buzz during the meetings. Many exhibitors voiced the opinion that the telehealth markets are at a tipping point. It appears that the best approach among early entrants to meet the rising demand for telehealth services will be to join forces. This will result in a market shakeout that will enable companies to increase their scale while growing revenues. There was a definite sentiment among attendees and exhibitors that additional acquisition activity will occur in the short term. Three keynote speakers presented their views of the telehealth market landscape. Attendees also had the opportunity to create a customized agenda based on four major tracks and several content format options. The large exhibit hall appeared to be less well-attended than in past years, which worried some exhibitors. It was also observed that several notable telehealth companies did not have exhibits. Among those that did exhibit, it appeared that the market messages were focused on the value and end-to-end services offered by telehealth providers rather than specific products or technology specifications. The bottom line is that for those industry stakeholders who needed to increase their awareness and contacts with telehealth leaders, ATA 18 was the place to be. This growth insight presents an analysis of the major themes in telehealth in 2018, noteworthy vendor developments observed at ATA 2018, key findings from the event, and analyst opinion on what this means for the market moving forward. Vendors discussed include American Well, MDLIVE, Honeywell Life Care, Philips, TytoCare, GlobalMed, AMD Global Telemedicine, and Vivify Health.
Published: May 30 2018 Other
Many New Services Evolving from Digital Health and mHealth are Expected to Drive Growth, Reduce Healthcare Costs, and Improve Patient Outcomes
Digital therapeutics are about to become a true medical alternative that will utilize communications-based technologies, apps, and software to improve patient outcomes and help to lower the cost of healthcare. The overall digital therapeutics market is expected to grow at a compound annual growth rate of 30.7% from 2017 to 2023. This report emphasizes the importance of clearly defining the term "digital therapeutics." In many areas of the evolving healthcare market, an important facet of understanding opportunity and strategy is effective definition and scoping of new terminology and concepts. Frost & Sullivan reviews data that illustrate there is often an inconsistent definition of the term as well as the companies that are participating in this early market. The research reveals that there is a much smaller segment of the digital therapeutics market devoted to pure play participants that are developing true therapeutic solutions that will provide a medical-grade benefit to patients. The pure play market will require considerable research and development in partnership with pharmaceutical companies, and a US Food and Drug Administration certification for safety and efficacy after a clinical trial. Frost & Sullivan predicts that the digital therapeutics market will attract the interests of medical device companies, pharmaceutical industry participants, and investors. It is reasonable to foresee that several of the larger, established healthcare companies will carefully monitor progress in this space and make strategic moves as the smaller, new entrants demonstrate successful outcomes following randomized clinical trials.
Published: May 25 2018 Market Research
Top Digital Health Takeaways and Analyst Perspectives
The Connected Health Conference is one of the leading digital health events in the US market. The theme of the 2017 conference was: “The Connected Life Journey: Shaping Health and Wellness for Every Generation.” The goal was to place less emphasis on the bells and whistles of technology while focusing more on the human element of connected health. Frost & Sullivan was in attendance and presents highlights, opinions, and market predictions emerging from this signature industry event. Healthcare’s digitization is leading to an explosion of electronic data across all healthcare industry segments. Health-related digital data is pouring in from a variety of sources including electronic health records, billing and medical claim systems, and a plethora of health monitoring devices. Profound changes are occurring in the day-to-day practice of medicine as well as the core operations of providers. New approaches are essential and inevitable to ensure the transition to an era in healthcare that emphasizes quality and safety, coordinated patient care, evidence-based medicine, outcome-based reimbursement, efficient resource allocation, and increased engagement of consumers and patients. This Growth Insight includes a high-level overview of the conference and keynote addresses from Dr. Joseph Kvedar, Partners HealthCare; Dr. Adrienne Boissy, Cleveland Clinic; Rick Valencia, Qualcomm Life; Carla Kriwet, Philips Connected Healthcare and Informatics; and Dr. Calum MacRae, Brigham and Women’s Hospital. Analyst-identified key takeaways also are presented. Developments of company in attendance also are discussed. They include Bosch Healthcare, Intel Corporation, MediSafe, Medtronic, AllazoHealth, Orbita, Philips and Validic.
Published: Dec 28 2017 Other
Fitbit is Losing Steps as the Wearable Market Matures
Digital health brings a diverse range of growth opportunities for vendors across the value chain. As the space has evolved, it has experienced a multitude of small successes and stellar failures, yet funding continues to flood in. Major entries into the industry continue from the broader vendor environment, underlining the importance of health in everyone’s lives and in the strategic interests of the C-Suite across the ecosystem. Over the past 10 years, Fitbit has become a household name in the wearable market synonymous with fitness wearables and activity tracking. The company went public in 2015 and reported revenue growth that surpassed the $2 billion mark in 2016. However, the 4th quarter of 2016 was disappointing and was followed by a revenue guidance for 2016 of a decline to $1.5 billion to $1.7 billion. The wearable market overall has reached maturity and a shift in market conversation from its height of hype in the middle of the decade. This has brought challenging times for many companies as they seek to continue to uncover growth opportunities through activities such as portfolio changes and acquisitions in light of once major brands dissipating including Jawbone, Basis, and Nike. This report examines Fitbit's current situation, which includes both opportunities to rebound and threats of continued declines. It reviews the industry dynamics that Fitbit must overcome to encourage customers, partners and investors to remain confident. Fitbit must increase its competitiveness in the smartwatch market against the likes of Apple, Samsung, and Fossil. Although it has made key acquisitions that have added smartwatch intellectual property and executive talent, its future is far from certain. Key questions this study will answer: - What are the strengths, weaknesses, opportunities, and threats facing Fitbit? - What factors will Fitbit need to manage strategically in order to regain its momentum in the market?
Published: Oct 25 2017 Other
Telehealth, sometimes referred to as telemedicine, is a combination of telecommunication services combined with advanced medical device technology and cloud-based platforms used to deliver healthcare to patients not in the same physical location as the provider or care giver.
Published: Sep 28 2017 Market Insights
Opportunities to Offer a Variety of Telebehavioral Health Services Will Drive New Growth in Digital Health
The latest report in the Frost & Sullivan's telehealth series finds that telemental health services and communications enablers are poised to increase in utilization because they offer a therapeutic environment similar to traditional in-person methods, minus the time and costs associated with traveling to a treatment site—assuming one is even available. Overall telemental health market revenue is expected to increase at a compound annual growth rate of 22.5% from 2016 to 2021. This report reviews the data that illustrates the magnitude of mental health and substance abuse issues prevalent across the United States coupled with the documented lack of nearby mental health professionals in many locations. The research shows examples of several ongoing programs that have made strides despite a variety of barriers, such as the lack of a standard reimbursement process across states, that must be overcome for these services to achieve their full potential. This report also covers a mix of pure-play telemental health specialists and telehealth companies that have extended their service to include telebehavioral health services, including InSight Telepsychiatry, American Well, Teladoc, MDLIVE , Vidyo, and WeCounsel. Major questions this report will answer include: • What are the latest trends impacting the telemental health space? • How is the telemental market segmented, and who are the major participants in each segment? • What combination of economic supply and demand factors and mental health condition and substance abuse prevalence statistics appear to make the wide-scale adoption of telemental health inevitable? • What are the competitive characteristics of the telemental health market, and who are some of the key vendors serving the market and the segments? • What is the 5-year revenue outlook for the market and the major segments? Frost & Sullivan found that telemental health services have the potential to become the most successful telehealth application within the next five years. The industry will benefit from the prevalence of mental health and behavioral issues. By 2021, telemental health services will gain recognition as a proven solution to the challenge faced by people who have little or no access to mental health professionals.
Published: Sep 26 2017 Market Research
Yorktel Introduces Univago HE™   Yorktel today introduced Univago HE described as the first and only all-inclusive telemedicine video services platform that delivers the versatility, reliability and security vital to affecting widespread telemedicine adoption.  Yorktel indicated that it designed the product from the ground up explicitly for telem...
05 Sep 2017 Blog post
Industry Confirms Telemedicine’s Value While the Question Persists—Is Anyone Making Money?
The American Telemedicine Association held its annual meeting in Orlando, Florida from April 23-25, 2017. This year’s conference was called Telehealth 2.0 and drew attendees from healthcare providers as well as a mix of established and start-up telehealth-focused companies. This growth insight presents an analysis of key takeaways and major themes of importance in telehealth in 2017, noteworthy vendor developments, findings from the event and analyst opinion on what this means for the area. Among the major themes included are the need for the industry to get past trials, achieve larger scale implications and the ongoing challenges posed by the lack of a standard reimbursement model across all regions and demographic groups.
Published: May 29 2017 Other
Connected Healthcare Expected to Drive Growth
Clinical Decision Support Systems and services have evolved from being an authoritative content market dominated by large Scientific, Medical, and Technical (STM) publishers to being a dynamic and evolving connected infrastructure that includes digital workflow, electronic health record (EHR), and a variety of point-of-care solutions. While clinical guidelines and protocols remain critical components of this market, the landscape now includes a mix of suppliers, including medical device manufacturers and cloud-based clinical surveillance tools. The overall CDSS market is expected to grow by a CAGR of 8.9% from 2016 to 2021. Point-of-care solutions will be a key area of market growth. EHR providers will strive to become the hub of a CDSS, either by integrating access to CDS sources from within the EHR or through links to sources that have partnering agreements with the EHR provider. Workflow solutions, such as Computerized Physician Order Entry Systems (CPOE), documentation and scheduling sources, in addition to charge capture capabilities are also important in the market. One exciting aspect of CDSS in the digital era is the growing volume of patient data derived from medical devices, and monitoring systems, both from within the hospital and remotely. Additional scores of data signal expanded opportunities for new data analytics systems and models. This growing cache of medical data should support breakthroughs in Population Health Management Systems. Perhaps, the most exciting segment within CDSS is clinical surveillance systems that are capable of spotting serious patient-related issues with even more reliability than expert medical staffers. These systems use advanced data models to spot, at the point-of-care, nuances among the complex mix of medical indicators that may signal the prelude for a serious-yet-preventable medical event. This report also covers an array of established and new industry participants offering services in the segments covered, such as Wolters Kluwer, Zynx Health, The American College of Radiology, athenahealth, Philips, Elsevier, HCA, Premier, IBM (Truven), Inovalon, eClinical Works, Epic, Meditech, Perigen, Isabel Health, Motive Medical Intelligence, and many others. Major questions this research will answer include: • What are the major trends impacting the CDSS space? • What are the major participants across CDSS and by market segment? • What are the competitive dynamics of the CDSS market? • What is the revenue outlook for CDSS and the major segments? • What are the strategic imperatives and calls to action that will define growth and success within the CDSS market over the next five years? Frost & Sullivan predicts that CDSS will evolve to become advanced predictive analytic tools, based on input from a patient’s history, next-generation sequencing, and patient-generated data. Complex machine learning algorithms, artificial intelligence, and cognitive computing will influence advances in CDSS over the coming decades. The report also predicts the growing importance for patients to have access to CDSS from reliable medical-grade sources.
Published: May 18 2017 Market Research
Highlights from the 2016 American Heart Association Innovation Forum, April 20, 2016 Lack of Incentive for Funding in Cardiovascular Disease Rises Challenges in the Industry NYC Heart & Stroke Innovation event provided insight on the challenges and growth opportunities in the cardiovascular disease industry On April 20, 2016, The American Heart...
25 Apr 2016 Blog post
There are a couple of items worth mentioning since last week's surprise announcement from Healthspot.   Today MedCity News published a report stating that despite the demise of Healthspot, Xerox, one of the principal investors and developer of the technology powering the kiosks, remains bullish on the concept and wants to leverage the concept els...
11 Jan 2016 Blog post
In a way, the events surrounding Healthspot are very similar to when Robert Bosch Health Systems Inc., exited the U.S. telehealth and remote patient monitoring (RPM) markets last year. In both cases, the move was very sudden despite notable contracts; Bosch with Veterans Affairs and Healthspot with Rite Aid, the Cleveland Clinic and others.   So...
08 Jan 2016 Blog post

Victor's Tweets

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..